Dupilumab Reduces Exacerbations in Patients With COPD

THURSDAY, May 25, 2023 -- For patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, dupilumab is associated with fewer moderate-to-severe exacerbations, according to a study published online May 21 in the New England...